Cencora Q1 Earnings Preview: Specialty and International Momentum Expected to Boost Results

jueves, 29 de enero de 2026, 9:52 am ET1 min de lectura
COR--

Cencora is set to report Q1 FY26 results on Feb 4. The Zacks Consensus Estimate for revenues is $85.97 billion, up 5.5% YoY, and earnings are expected to be $4.05 per share, an 8.6% improvement. The company's strong performance is likely driven by sustained pharmaceutical utilization trends and the growing contribution from specialty-focused assets, despite certain headwinds tempering growth.

Cencora Q1 Earnings Preview: Specialty and International Momentum Expected to Boost Results

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios